Form 4 for INSM INSMED Inc
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0001628280-25-052361 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-14 | 2025-11-12 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | S - Sale+OE | $194.00 | -30.0K | 36.6K | -45% | -$5.82M |
| D | 2025-11-14 | 2025-11-12 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $26.46 | +30.0K | 66.5K | +82% | +$793.8K |
| D | 2025-11-14 | 2025-11-12 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Off | M - OptEx | $0.00 | -30.0K | 15.8K | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | S | D | 164 | $195.88 | 36,461 | D | — | — | (F4) This is the weighted average sales price representing 164 shares sold at prices ranging from $195.42 to $195.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2025-11-12 | M | A | 30,000 | $26.46 | 66,461 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-12 | S | D | 4,078 | $192.45 | 62,383 | D | — | — | (F1) This is the weighted average sales price representing 4,078 shares sold at prices ranging from $192.00 to $192.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2025-11-12 | S | D | 6,575 | $193.64 | 55,808 | D | — | — | (F2) This is the weighted average sales price representing 6,575 shares sold at prices ranging from $193.02 to $194.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Common | Common Stock | 2025-11-12 | S | D | 19,183 | $194.44 | 36,625 | D | — | — | (F3) This is the weighted average sales price representing 19,183 shares sold at prices ranging from $194.02 to $194.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 6 | Derivative | Stock Option (right to buy) | 2025-11-12 | M | D | 30,000 | $0.00 | 15,760 | D | $26.46 · — to 2031-05-12 | 30,000 Common Stock | (F5) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |